Arm Holdings (ARM) Revenue Up 26% as Wall Street Raise Price Targets

TLDR

• Needham upgraded ARM to Buy from Hold, setting a $200 price target
• ARM unveiled its first in-house AGI CPU chip at its “Arm Everywhere” event
• Meta signed on as the launch customer for ARM’s new silicon
• Jefferies raised its price target to $210, citing potential for $15B in added revenue by FY2031
• ARM last quarter beat EPS estimates ($0.43 vs $0.41) with revenue up 26.3% year-over-year

Needham upgraded Arm Holdings to Buy on Wednesday after holding a neutral stance for two and a half years, setting a 12-month price target of $200.

Arm Holdings plc American Depositary Shares, ARM

The firm pointed to ARM’s moves in the silicon market — raising royalty rates, expanding into subsystems, and now building its own chips. Needham said these strategies are starting to pay off.

ARM has posted 26.45% revenue growth over the last twelve months. Nineteen analysts have revised their earnings estimates upward for the upcoming period.

A key part of the upgrade thesis is ARM’s entry into the silicon market through Meta Platforms. Meta has signed on as the launch customer for ARM’s first in-house chip, the AGI CPU, giving the product a high-profile commercial anchor from day one.

The AGI CPU was unveiled at ARM’s “Arm Everywhere” event. Jefferies raised its price target to $210 from $170 after the event, pointing to the chip’s potential to generate $15 billion in additional revenue by fiscal year 2031.

Barclays reiterated an Overweight rating and lifted its target to $200 from $165. The bank highlighted the energy efficiency of the AGI CPU design as a key advantage for AI workloads.

BofA Securities raised its target to $155 from $140 but held a Neutral rating. Morgan Stanley kept its Overweight rating with a $135 target, noting ARM’s dual-chiplet CPU design for AI cloud use cases.

Analyst Consensus

The current street consensus sits at a Moderate Buy, with an average price target of $168.17. That’s based on 19 Buy ratings, 6 Holds, and 1 Sell.

ARM’s 50-day moving average stands at $120.72, and the 200-day sits at $134.17. The stock has a 52-week range of $80.00 to $183.16 and a market cap of around $165.95 billion.

The company’s P/E ratio is 209. InvestingPro flags the stock as currently overvalued relative to its Fair Value estimate.

In its most recent quarter, ARM reported EPS of $0.43, beating estimates of $0.41. Revenue came in at $1.24 billion, up 26.3% year-over-year and slightly ahead of the $1.23 billion consensus.

Q4 Guidance

ARM set its Q4 FY2026 guidance at $0.54 to $0.62 EPS. Analysts as a group forecast full-year EPS of $0.90.

Needham noted the rise of agentic AI and the growing role of CPUs in AI data centers as longer-term tailwinds for ARM’s positioning.

The AGI CPU is built for agentic AI workloads, featuring a many-core, power-efficient design. Analysts note the chip will need software and hardware ecosystem support to compete with entrenched rivals including Nvidia, Intel, and AMD.

Susquehanna upgraded ARM from Neutral to Positive in January with a $150 target. Mizuho cut its target from $190 to $160 in February but maintained an Outperform rating.

Institutional ownership stands at 7.53% of the stock.

The post Arm Holdings (ARM) Revenue Up 26% as Wall Street Raise Price Targets appeared first on CoinCentral.